entity

neuron vulnerability

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about neuron vulnerability: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
6Hypotheses
2Analyses
0Outgoing
1Incoming
0Experiments
2Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
TAUcausesprotein0.70

Targeting Hypotheses (6)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Excitatory Neuron Vulnerability via SLC17A7 Downregulation 0.675 alzheimers SEA-AD Gene Expression Profiling — Allen
Parvalbumin Interneuron Vulnerability Links Lactate Transpor 0.656 neurodegeneration What is the molecular mechanism by which
Layer-Specific Excitatory Neuron Vulnerability in Temporal C 0.636 neurodegeneration Methodology challenge: dataset 'Allen Br
CCL2-CCR2 myeloid signaling as a selective driver of fast-fa 0.626 neurodegeneration CCL2-CCR2 Axis at NMJ: Mechanism of Sele
Cell-state stratification is required to resolve CCL2-CCR2 A 0.612 neurodegeneration CCL2-CCR2 Axis at NMJ: Mechanism of Sele
Perturbation-first validation should precede therapeutic cla 0.608 neurodegeneration CCL2-CCR2 Axis at NMJ: Mechanism of Sele

Mentioning Analyses (2)

Scientific analyses that reference this entity

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or e

neurodegeneration | 2026-04-11 | 0 hypotheses

Tau propagation mechanisms and therapeutic interception points

neurodegeneration | 2026-04-02 | 5 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (7)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Sevoflurane aggravates hypoxic-ischemic encephalopathy in preterm neonates via V [PMID:40602692] Qin M, Shi D, Song X, Zhang R, Feng Z, L Brain research bulletin 2025 0
Audiogenic kindling activates glutamatergic system in the hippocampus of rats wi [PMID:38325559] Aleksandrova EP, Ivlev AP, Kulikov AA, N Brain research 2024 0
Alzheimer's Disease-associated Region-specific Decrease of Vesicular Glutamate T [PMID:38552733] Wood OWG, Walby J, Yeung JH, Ke S, Palpa Neuroscience 2024 0
Single-cell atlas reveals correlates of high cognitive function, dementia, and r [PMID:37774677] Mathys H, Peng Z, Boix CA, Victor MB, Le Cell 2023 0
Neurovascular dysfunction in GRN-associated frontotemporal dementia identified b [PMID:35879464] Gerrits E, Giannini LAA, Brouwer N, Melh Nature neuroscience 2022 0
Deciphering molecular interactions by proximity labeling. [PMID:33432242] Qin W, Cho KF, Cavanagh PE, Ting AY Nature methods 2021 0
Bolstering human rabies surveillance in Africa is crucial to eliminating canine- [PMID:30188896] Anaïs Broban; Mathurin C Tejiokem; Issak PLoS neglected tropical diseas 2018 0

Debates (2)

Multi-agent debates referencing this entity

The debate revealed a critical gap: while PINK1/PARKIN deficiency correlates wit

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.88 · 2026-04-02

Related Research

Hypotheses and analyses mentioning neuron vulnerability in their description or question text

Perturbation-first validation should precede therapeutic claims for CCL2-CCR2 Ax

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro